Exposure to apoptotic activated CD4+ T cells induces maturation and APOBEC3G- mediated inhibition of HIV-1 infection in dendritic cells

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Mohanram, Venkatramanan ^a   Johansson, Ulrika ^a   Sköld, Annette E ^a   Fink, Joshua ^a   Pathak, Sushil Kumar ^a   Mäkitalo, Barbro ^a   Walther Jallow, Lilian ^a   Spetz, Anna Lena ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CD86 ANTIGEN; DINUCLEOTIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN APOACT; PROTEIN APOINF; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; APOBEC3G PROTEIN, HUMAN; CHEMOKINE; CYTIDINE DEAMINASE; CYTOKINE; PRIMER DNA;

APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DNA BASE COMPOSITION; DNA ISOLATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOPATHOGENESIS; INFECTION RATE; LYMPHOCYTE ACTIVATION; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SOMATIC HYPERMUTATION; VIRUS ENVELOPE; CELL DIFFERENTIATION; CULTURE MEDIUM; CYTOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SECRETION; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

APOPTOSIS; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CHEMOKINES; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; CYTIDINE DEAMINASE; CYTOKINES; DENDRITIC CELLS; DNA PRIMERS; HUMANS; POLYMERASE CHAIN REACTION;

EID: 79959279099     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021171     Document Type: Article

References (57)

1. Banchereau J, Steinman RM, (1998) Dendritic cells and the control of immunity. Nature 392: 245-252.
2. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S, (2002) Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20: 621-667.
3. Bakri Y, Schiffer C, Zennou V, Charneau P, Kahn E, et al. (2001) The maturation of dendritic cells results in postintegration inhibition of HIV-1 replication. J Immunol 166: 3780-3788.
4. Blander JM, Medzhitov R, (2006) Toll-dependent selection of microbial antigens for presentation by dendritic cells. 440 Nature: 808-12.
5. Schulz O, Diebold SS, Chen M, Naslund TI, Nolte MA, et al. (2005) Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433: 887-892.
6. Gringhuis SI, van der Vlist M, van den Berg LM, den Dunnen J, Litjens M,et al. HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells. Nat Immunol 11: 419-426.
7. Piguet V, Steinman RM, (2007) The interaction of HIV with dendritic cells: outcomes and pathways. Trends Immunol 28: 503-510.
8. Coleman CM, Wu L, (2009) HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology 6: 51.
9. Hu Q, Frank I, Williams V, Santos JJ, Watts P, et al. (2004) Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. J Exp Med 199: 1065-1075.
10. Cavrois M, Neidleman J, Kreisberg JF, Fenard D, Callebaut C, et al. (2006) Human immunodeficiency virus fusion to dendritic cells declines as cells mature. J Virol 80: 1992-1999.
11. Granelli-Piperno A, Delgado E, Finkel V, Paxton W, Steinman RM, (1998) Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-tropic virus to T cells. J Virol 72: 2733-2737.
12. Alkhatib G, (2009) The biology of CCR5 and CXCR4. Curr Opin HIV AIDS 4: 96-103.
13. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, et al. (1995) Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells [see comments]. Science 270: 1811-1815.
14. Vicenzi E, Biswas P, Mengozzi M, Poli G, (1997) Role of pro-inflammatory cytokines and beta-chemokines in controlling HIV replication. J Leukoc Biol 62: 34-40.
15. Geonnotti AR, Bilska M, Yuan X, Ochsenbauer C, Edmonds TG, et al. (2010) Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production. AIDS Res Hum Retroviruses 26: 279-291.
16. Folks T, Powell DM, Lightfoote MM, Benn S, Martin MA, et al. (1986) Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency. Science 231: 600-602.
17. Clouse KA, Powell D, Washington I, Poli G, Strebel K, et al. (1989) Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J Immunol 142: 431-438.
18. Osborn L, Kunkel S, Nabel GJ, (1989) Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci U S A 86: 2336-2340.
19. Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB, (1989) Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc Natl Acad Sci U S A 86: 5974-5978.
20. Griffin GE, Leung K, Folks TM, Kunkel S, Nabel GJ, (1989) Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B. Nature 339: 70-73.
21. Herbein G, Montaner LJ, Gordon S, (1996) Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor. J Virol 70: 7388-7397.
22. Arrighi JF, Rebsamen M, Rousset F, Kindler V, Hauser C, (2001) A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J Immunol 166: 3837-3845.
23. Albin JS, Harris RS, (2010) Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics. Expert Rev Mol Med 12: e4.
24. Harris RS, Liddament MT, (2004) Retroviral restriction by APOBEC proteins. Nat Rev Immunol 4: 868-877.
25. Pion M, Granelli-Piperno A, Mangeat B, Stalder R, Correa R, et al. (2006) APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection. J Exp Med 203: 2887-2893.
26. Zhao XQ, Huang XL, Gupta P, Borowski L, Fan Z, et al. (2002) Induction of anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) and CD4(+) T-cell reactivity by dendritic cells loaded with HIV-1 X4- infected apoptotic cells. J Virol 76: 3007-3014.
27. Larsson M, Fonteneau JF, Lirvall M, Haslett P, Lifson JD, et al. (2002) Activation of HIV-1 specific CD4 and CD8 T cells by human dendritic cells: roles for cross-presentation and non-infectious HIV-1 virus. Aids 16: 1319-1329.
28. Maranon C, Desoutter JF, Hoeffel G, Cohen W, Hanau D, et al. (2004) Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4+ T lymphocytes. Proc Natl Acad Sci U S A 101: 6092-6097.
29. Johansson U, Walther-Jallow L, Smed-Sorensen A, Spetz AL, (2007) Triggering of dendritic cell responses after exposure to activated, but not resting, apoptotic PBMCs. J Immunol 179: 1711-1720.
30. Hladik F, McElrath MJ, (2008) Setting the stage: host invasion by HIV. Nat Rev Immunol 8: 447-457.
31. Gougeon ML, Piacentini M, (2009) New insights on the role of apoptosis and autophagy in HIV pathogenesis. Apoptosis 14: 501-508.
32. Smed-Sorensen A, Lore K, Walther-Jallow L, Andersson J, Spetz AL, (2004) HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation. Blood 104: 2810-2817.
33. Spetz AL, Patterson BK, Lore K, Andersson J, Holmgren L, (1999) Functional gene transfer of HIV DNA by an HIV receptor-independent mechanism. J Immunol 163: 736-742.
34. Bergsmedh A, Szeles A, Henriksson M, Bratt A, Folkman MJ, et al. (2001) Horizontal transfer of oncogenes by uptake of apoptotic bodies. Proc Natl Acad Sci U S A 98: 6407-6411.
35. Obeid M, Panaretakis T, Joza N, Tufi R, Tesniere A, et al. (2007) Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis. Cell Death Differ 14: 1848-1850.
36. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, et al. (2009) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16: 3-11.
37. Connor RI, Notermans DW, Mohri H, Cao Y, Ho DD, (1993) Biological cloning of functionally diverse quasispecies of HIV-1. AIDS Res Hum Retroviruses 9: 541-546.
38. Flint SJEW, Racaniello VR, Skalka AM, eds. (2009) Virological Methods. Principles in Virology: ASM Press.
39. Yun Z, Fredriksson E, Sonnerborg A, (2002) Quantification of human immunodeficiency virus type 1 proviral DNA by the TaqMan real-time PCR assay. J Clin Microbiol 40: 3883-3884.
40. Lee C, Kim J, Shin SG, Hwang S, (2006) Absolute and relative QPCR quantification of plasmid copy number in Escherichia coli. J Biotechnol 123: 273-280.
41. Jeffrey PL, Wang Y, Seidl T, Babaahmady K, Vaughan R, et al. (2009) The effect of allogeneic in vitro stimulation and in vivo immunization on memory CD4(+) T-cell APOBEC3G expression and HIV-1 infectivity. Eur J Immunol 39: 1956-1965.
42. Sui Y, Zhu Q, Gagnon S, Dzutsev A, Terabe M, et al. (2010) Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques. Proc Natl Acad Sci U S A 107: 9843-9848.
43. Pido-Lopez J, Wang Y, Seidl T, Babaahmady K, Vaughan R, et al. (2009) The effect of allogeneic in vitro stimulation and in vivo immunization on memory CD4(+) T-cell APOBEC3G expression and HIV-1 infectivity. Eur J Immunol 39: 1956-1965.
44. Piantadosi A, Chohan B, Chohan V, McClelland RS, Overbaugh J, (2007) Chronic HIV-1 infection frequently fails to protect against superinfection. PLoS Pathog 3: e177.
45. Knoepfel SA, Salisch NC, Huelsmann PM, Rauch P, Walter H, et al. (2008) Comparison of G-to-A mutation frequencies induced by APOBEC3 proteins in H9 cells and peripheral blood mononuclear cells in the context of impaired processivities of drug-resistant human immunodeficiency virus type 1 reverse transcriptase variants. J Virol 82: 6536-6545.
46. Stevceva L, Ferrari MG, (2005) Mucosal adjuvants. Curr Pharm Des 11: 801-811.
47. Bruhl P, Kerschbaum A, Zimmermann K, Eibl MM, Mannhalter JW, (1996) Allostimulated lymphocytes inhibit replication of HIV type 1. AIDS Res Hum Retroviruses 12: 31-37.
48. Dong C, Janas AM, Wang JH, Olson WJ, Wu L, (2007) Characterization of human immunodeficiency virus type 1 replication in immature and mature dendritic cells reveals dissociable cis- and trans-infection. J Virol 81: 11352-11362.
49. Peters B, Whittall T, Babaahmady K, Gray K, Vaughan R, et al. (2004) Effect of heterosexual intercourse on mucosal alloimmunisation and resistance to HIV-1 infection. Lancet 363: 518-524.
50. Peng G, Greenwell-Wild T, Nares S, Jin W, Lei KJ, et al. (2007) Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood 110: 393-400.
51. Kabelitz D, Janssen O, (1997) Antigen-induced death of T-lymphocytes. Front Biosci 2: d61-77.
52. Ferguson TA, Kazama H, (2005) Signals from dying cells: tolerance induction by the dendritic cell. Immunol Res 32: 99-108.
53. Morelli AE, Larregina AT, (2010) Apoptotic cell-based therapies against transplant rejection: role of recipient's dendritic cells. Apoptosis 9: 1083-97.
54. Douek D, (2007) HIV disease progression: immune activation, microbes, and a leaky gut. Top HIV Med 15: 114-117.
55. Gougeon ML, (2005) To kill or be killed: how HIV exhausts the immune system. Cell Death Differ 12 (Suppl 1): 845-854.
56. Sakai K, Dimas J, Lenardo MJ, (2006) The Vif and Vpr accessory proteins independently cause HIV-1-induced T cell cytopathicity and cell cycle arrest. Proc Natl Acad Sci U S A 103: 3369-3374.
57. Paiardini M, Pandrea I, Apetrei C, Silvestri G, (2009) Lessons learned from the natural hosts of HIV-related viruses. Annu Rev Med 60: 485-495.